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ABSTRACT For many general anesthetics, their molecular basis of action involves interactions with GABAA receptors.
Anesthetics produce concentration-dependent effects on GABAA receptors. Low concentrations potentiate submaximal GABA-
induced currents. Higher concentrations directly activate the receptors. Functional effects of anesthetics have been char-
acterized, but little is known about the conformational changes they induce. We probed anesthetic-induced conformational changes
in the M2 membrane-spanning, channel-lining segment using disulﬁde trapping between engineered cysteines. Previously, we
showed that oxidation by copper phenanthroline in the presence of GABA of the M2 69 cysteine mutants, a1T261Cb1T256C and
a1b1T256C resulted in formation of an intersubunit disulﬁde bond between the adjacent b-subunits that signiﬁcantly increased the
channels’ spontaneous open probability. Oxidation inGABA’s absence had no effect.We examined the effect on a1T261Cb1T256C
and on a1b1T256C of oxidation by copper phenanthroline in the presence of potentiating and directly activating concentrations of
the general anesthetics propofol, pentobarbital, and isoﬂurane.Oxidation in the presenceof potentiating concentration of anesthetics
had little effect. Oxidation in the presence of directly activating anesthetic concentrations signiﬁcantly increased the channels’
spontaneous open probability. We infer that activation by anesthetics and GABA induces a similar conformational change at the M2
segment 69 position that is related to channel opening.
INTRODUCTION
The GABAA receptors are a major molecular target for
general anesthetics such as pentobarbital, propofol, and
isoﬂurane (1–5). Each of these anesthetics has three separate
effects on GABAA receptors. Low concentrations potentiate
currents induced by submaximal GABA concentrations.
Higher anesthetic concentrations directly activate receptors
in GABA’s absence. At still higher concentrations many an-
esthetics inhibit both anesthetic and GABA-induced currents
(4,5). These distinct actions imply that GABAA receptors
contain several distinct binding sites for each anesthetic. At
least for some anesthetics, these sites are distinct from the
GABA binding sites (6–8). Occupancy of these sites sta-
bilizes different receptor states or ensembles of states (9,10).
Consistent with this, we showed that the conformation of the
M3 membrane-spanning segment or the protein domains
surrounding it are different in the presence of potentiating
and activating concentrations of propofol, a commonly used
intravenous general anesthetic (11). Single-channel studies
have shown similar conductances but different kinetics after
activation by GABA and by general anesthetics (12,13). This
has led to the hypothesis that although the anesthetic binding
sites are distinct from the GABA binding sites, the open-state
channel structure is similar in the presence of GABA and the
anesthetics. There is, however, little structural information
available to support this hypothesis.
GABAA receptors are formed by ﬁve homologous sub-
units assembled around the central channel (14). A common in
vivo subunit stoichiometry is 2a:2b:1g subunits (15,16), but
functional receptors are also formed by coexpression of just
the a- and b-subunits with evidence supporting a stoichi-
ometry of 2a:3b (17–19) and of 3a:2b (20,21). Each subunit
has an ;200 amino acid extracellular N-terminal domain
and a similar sized C-terminal domain with four membrane-
spanning segments (M1, M2, M3, M4). The extracellular
domain structure is similar to that of the homologous ace-
tylcholine binding protein with the GABA-binding sites
located at the b-a subunit interfaces (22–24). The trans-
membrane channel is principally lined by the ﬁve largely
a-helical M2 segments (25,26). (To facilitate comparisons
with other receptors in the gene superfamily, we will refer to
M2 segment residues using an index numbering system in
which the conserved positively charged residue at the M2
cytoplasmic end is the 09 position, and residues toward the
C-terminus are numbered consecutively 09, 19, 29, . . . (27)
(Fig. 1).) The position and extent of the channel gate are
uncertain, but all agree that it lies somewhere between the
middle and cytoplasmic end of M2 (26,28–30).
We sought to determine whether the general anesthetics
pentobarbital, propofol, and isoﬂurane induced a similar con-
formational change in the M2 channel-lining segments as
that induced during GABA activation. As a reporter for the
conformational state of the M2 segments, we used disulﬁde
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trapping experiments with the 69 engineered cysteine (Cys)
mutants a1T261Cb1T256C and a1b1T256C. Previously, we
showed that disulﬁde bond formation between engineered
M2 segment cysteine (Cys) residues at the 69 level was state
dependent (Fig. 1) (31). Oxidation in the closed state had no
effect. In contrast, in the presence of GABA, oxidation by
copper phenanthroline (Cu:phen) caused disulﬁde bond
formation between the adjacent b-subunits that resulted in
a signiﬁcant increase in the macroscopic holding current
after GABA washout (31). This increased holding current
presumably resulted from an increase in the channel’s
spontaneous open probability. We inferred that the disulﬁde
bond formed between adjacent b-subunits because if it
formed between nonadjacent b-subunits, the channel lumen
would have been obliterated and that would be inconsistent
with the increased holding current that we observed. A
corollary to this conclusion is that with our expression
conditions most of the receptors had a subunit stoichiometry
of 2a:3b subunits. Furthermore, we inferred that in the
presence of GABA, the proximity and orientation of the
engineered Cys residues in the adjacent b-subunits were
more favorable than in the closed state. Thus, the ability to
form the 69 disulﬁde bond provides a reporter for the open
state structure of the M2 segments in this region of the
channel.
Cu:phen promotes oxidation by catalyzing the formation
of hydroxyl radicals and superoxide; it does not require
direct contact between the Cu:phen and the sulfhydryls
(32,33). Disulﬁde trapping has been used to study protein
proximity and mobility relationships between residues in
both water-soluble and integral-membrane proteins (32,34,35).
The average a-carbon separation of disulﬁde-bonded Cys
residues is ;5.6 A˚ in proteins of known structure (32). The
disulﬁde bond formation rate depends on the collision
frequency of the sulfhydryls, the energy of the collision, and
the presence of an oxidizing environment (32). The collision
frequency depends on the average separation distance of the
sulfhydryls, their relative orientation in the protein, and
the mobility and/or ﬂexibility of the protein, especially in the
regions containing the Cys residues.
Our results show that GABA induced a conformational
change that allows disulﬁde bond formation between M2 69
engineered cysteine residues. At potentiating concentrations,
the anesthetics do not induce a similar conformational change,
but at directly activating concentrations, the anesthetics in-
duce a conformational change similar to that induced by
GABA.
MATERIALS AND METHODS
Mutants and expression
The rat a1 and b1 M2 segment cysteine-substitution mutants in the
pGEMHE plasmid were generated and characterized previously (31). Plas-
mid DNA was linearized with NheI for mRNA template synthesis. mRNA
was synthesized by in vitro transcription using the T7 AmpliScribe kit
(Epicenter, Madison, WI). Xenopus laevis oocyte preparation and injection
were as described previously (31). Oocytes were injected with 50 nl of a 200
pg/nl solution of mRNA in a 1:1 ratio of a:b subunits and maintained at
17C in OR3 medium as described previously (31).
Electrophysiology
Two-electrode voltage-clamp recording from Xenopus oocytes and data
acquisition and analysis were performed as described previously (25,31).
Brieﬂy, the data acquisition system utilized a TEV-200 ampliﬁer (Dagan,
Minneapolis, MN), Digidata 1322A interface, and pClamp 8.2 software
(Axon Instruments, Union City, CA). Electrodes were ﬁlled with 3 M KCl
and had resistances of less than 2 MV. Bath electrode was connected via a 3
M KCl/agar bridge. Oocytes, in a 250-ml recording chamber, were con-
tinuously perfused at 5 ml/min with calcium-free frog Ringer’s (CFFR) (115
mM NaCl, 2.5 mM KCl, 1.8 mM MgCl2, 10 mM HEPES pH 7.5 with
NaOH) at room temperature. Holding potential was 60 mV. Before ex-
periments were performed on each oocyte, GABA test pulses were applied
at 5-min intervals until the successive current amplitudes varied by less
than 5%.
Oxidation was induced by a 1-min application of 100:400 mM Cu:phen
prepared freshly as described previously (31). Because the magnitude of the
change in holding current (DIhold) induced by Cu:phen application will
depend on the maximal GABA-induced current (IGABA,max) for a given
oocyte, we normalized DIhold by IGABA,max determined before anesthetic
application so that the changes in holding current after Cu:phen application
are reported as (DIhold/IGABA,max) 3 100.
Anesthetic concentration-response relationships
The anesthetic concentration-response relationships for potentiation and
direct activation were determined using EC10-EC20 GABA as a test
FIGURE 1 Aligned channel-lining residues in thea1 andb1M2membrane-
spanning segments. Position of the69 residues is highlighted in reverse contrast.
Index numbers are shown in the center to facilitate comparisons with other
members of the gene superfamily (27). Solid squares indicate channel-lining
positions, solid circles non-channel-lining positions based on SCAM exper-
iments (25). Zn indicates the Zn21 binding site location at b1His267 (18), and
PTX indicates the picrotoxin binding site location at the 29 level (41).
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concentration. The oocytes were exposed to anesthetic alone for 10 to 20 s
and then to anesthetic 1 EC10-EC20 GABA for 10 s. Pretreatment with
potentiating concentrations of anesthetic enhances the potentiation of GABA-
induced current. When applied at activating concentrations, it allowed us
to measure the current induced by anesthetic in the absence of GABA.
Anesthetic applications were separated by washes lasting at least 5 min to
allow for anesthetic washout and full recovery from desensitization. It
should be noted that, particularly at high concentrations, anesthetic removal
was not always complete within a time frame of 10–20 min, probably
because the oocyte membrane acts as a reservoir for these hydrophobic
drugs. This was evident from the potentiation of subsequent submaximal
GABA applications. This was an issue for the higher concentrations used but
does not result in increased holding currents and thus does not affect the
interpretation of our experiments.
Expression in human embryonic kidney 293 cells
and single channel recording
Human embryonic kidney cells (HEK293T; American Tissue Culture
Collection, Manassas, VA) were grown at 37C in DMEM supplemented
with 10% fetal calf serum, 2.5 mM L-glutamine, 100 IU of penicillin, and
170 mM streptomycin in an atmosphere of 5% CO2/95% air. Cells were
seeded in 100-mm plates at a density of 1.2–1.5 3 106 cells and transfected
24 h later for 12 h using the calcium phosphate precipitation technique (36)
with 5–7 mg of plasmid DNA coding for GABAA a1 subunit, WT or T261C,
and 5–7 mg of plasmid DNA coding for GABAA b1 subunit, WT or T256C.
The plasmids were pXOON, a modiﬁed version of pXOOM (37), which
encodes a neomycin-enhanced green ﬂuorescent protein (eGFP) fusion
protein for the visual identiﬁcation of expression in transfected cells. Cells
were washed with PBS and detached with trypsin before reseeding at low
density in 35-mm polylysine-treated dishes that were mounted directly on
the stage of an inverted microscope (Zeiss IM; Zeiss, Thornwood, NY) for
patch-clamp experiments 24-48 h later. For single-cell recording in the cell-
attached conﬁguration of the patch clamp technique, pipettes were pulled
from thick-walled borosilicate glass, coated with Sylgard, and ﬁre-polished
to a resistance of 10–14 MV when ﬁlled with the internal solution. The
pipette contained 140 mM NaCl, 5 mM CsCl, 1 mM MgCl2, 2 mM CaCl2,
10 mM glucose, 10 mM HEPES, pH ¼ 7.4 adjusted with NaOH. Where
necessary, 5 mM GABA was diluted in the pipette solution. The same
medium was used for the bathing solution. The transfected cells chosen for
the experiments had similar GFP ﬂuorescence intensity. The pipette holding
potential was 160 mV (hyperpolarization of the cell). Currents were low-
pass ﬁltered at 8 kHz (eight-pole Bessel ﬁlter) and acquired at 20 kHz using
Pulse software interfaced with an EPC-9 ampliﬁer (HEKA, Darmstadt,
Germany). Where applicable, cells were treated for 20 min with Cu:phen
(100 mM:400 mM) in the presence of 5 mM GABA and thoroughly washed
before patching.
Reagents
Stock solutions of propofol (2,6-di-isopropylphenol) (ICN Biomedicals,
Aurora, OH) in DMSO were diluted into CFFR immediately before ap-
plication. The percentage of DMSO was never greater than 0.1% and had no
effect on GABA-induced currents (data not shown). Pentobarbital (Sigma
Chemical, St. Louis, MO) and isoﬂurane (1-chloro-2,2,2-triﬂuoroethyl
diﬂuoromethyl ether) (Halocarbon Laboratories, River Edge, NJ) were dis-
solved directly into CFFR buffer. Isoﬂurane solutions were prepared in
sealed plastic IV bags that contained no air bubbles immediately before use
(38). Teﬂon tubing was used for all perfusion tubing. Cu:phen was prepared
by diluting stock solutions of 100 mM CuSO4 and 1 M phenanthroline
(Sigma) in DMSO into CFFR immediately before use. DTT (Sigma) was
dissolved in CFFR immediately before use. Oocytes were perfused for 3–5
min between applications of GABA or reagents to allow complete recovery
from desensitization.
Data
Data are presented as mean6 SE. Statistical signiﬁcance was determined by
Student’s t-test except in Table 2, where one-way ANOVA with Dunnett’s
post hoc test was used.
RESULTS
Effects of disulﬁde bond formation between 69
cysteines at the single-channel level
Previously, we reported that oxidation of either a1T261Cb1
T256C (69) or a1b1T256C (69) GABAA receptors by a 1-min
application of 100:400 mM Cu:phen 1 GABA caused a
signiﬁcant increase in the subsequent holding current as
measured by two-electrode voltage-clamp recording from
Xenopus oocytes (31). We inferred that the increased holding
current was caused by an increase in the spontaneous open
probability of the channels after disulﬁde bond formation.
To investigate the basis for the increased holding current,
we performed single-channel patch-clamp recordings from
HEK293T cells expressing a1b1T256C receptors or from
cells transfected with empty pXOON vector. Transfected
cells were identiﬁed by GFP ﬂuorescence. As a control for
effects of Cu:phen application, we performed patch-clamp
recordings from cells transfected with empty vector, with no
GABA in the pipette. Under these conditions, no GABAA
receptor-like channels were observed in cell-attached patches
either before or after application of Cu:phen 1 GABA (n ¼
7) (data not shown).
With cells expressing a1b1T256C receptors, with GABA
in the pipette, we observed currents from GABAA receptor
channels in 88% of patches (43 of 49). The slope conduc-
tance of these channels was 23 6 1 pS (n ¼ 6). With no
GABA in the pipette, no GABA receptor-like channels were
observed in seven patches from cells expressing a1b1T256C
receptors (Fig. 2 A). In contrast, after cells expressing
a1b1T256C receptors were treated with Cu:phen 1 GABA,
with no GABA in the patch pipette, GABAA receptor
channels were present in 78% of patches (35 of 45) from
these cells (Fig. 2 B). The slope conductance of these
channels was 12 6 1 pS (n ¼ 4). The channels show bursts
of openings and ﬂickering between open and closed states.
Thus, the 69 disulﬁde bond increased the spontaneous open
probability of the channels, but they could still undergo rapid
transitions between the open and closed states.
Characterization of anesthetic effects on the 69
Cys mutants
The GABA EC50 reported previously for wild-type a1b1
GABAA receptors was 3.4 mM, and for the Cys mutants
a1T261Cb1 1.2 mM, a1b1T256C 1.0 mM, and a1T261Cb1
T256C 1.9 mM (31). For each anesthetic we identiﬁed
two concentrations, one that gave maximal potentiation of
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GABA-induced currents with little or no direct activation
and the second that gave signiﬁcant direct activation with
minimal inhibition.
As the propofol concentration was increased, direct
activation became signiﬁcant at ;10 mM propofol and
increased up to 40 mM propofol (Fig. 3 A). At higher con-
centrations the directly activated current diminished, pre-
sumably because of channel block (Fig. 3 A). The extent of
potentiation of GABA currents peaked at 10 mM propofol
and diminished at high concentrations (Fig. 3 A). In the
current traces at 20 mM propofol and above, we can see an
increase in current as GABA and propofol were washed out.
Transient washout currents like this usually indicate that
some fraction of the channels were blocked by the drug,
which washed out more rapidly than GABA. This suggests
that even at 20 mM propofol there is some channel block.
Quantiﬁcation of the anesthetic concentration-response rela-
tionship is difﬁcult because potentiation effects continue to
increase even after direct activation begins. Furthermore, at
higher concentrations, inhibition makes it difﬁcult to deter-
mine the maximal extent of potentiation and activation. The
results of similar experiments with pentobarbital (Fig. 3 B)
and isoﬂurane (Fig. 3 C) are shown. There was very little
direct activation with isoﬂurane at 3 mM, although there was
signiﬁcant potentiation (Fig. 3 C). At 20 mM isoﬂurane,
there was direct activation but a signiﬁcant amount of inhi-
bition as can be seen by the large washout currents when
isoﬂurane was applied by itself and with GABA (Fig. 3 C).
The anesthetic concentrations that we used in the subsequent
experiments are shown in Table 1.
Effect of Cu:phen oxidation in the presence of
potentiating anesthetic concentrations
We tested whether application of 100:400 mM Cu:phen in
the presence of a potentiating concentration of propofol
or pentobarbital altered the holding current or the subse-
quent GABA-induced currents of the double Cys mutant
a1T261Cb1T256C (Fig. 4). A 1-min application had little or
no effect on subsequent GABA-induced currents or on the
holding current at 60 mV (Table 2). In the presence of
propofol or pentobarbital, the holding current increased by
12% or 1% of IGABA,max, respectively. Similar results were
obtained in oocytes expressing a1b1T256C receptors (data
not shown). Likewise, a 1-min coapplication of 100:400 mM
Cu:phen and a potentiating concentration of isoﬂurane (1
mM) to oocytes expressing a1b1T256C receptors caused the
holding current to increase by 136 3% (n ¼ 3) of IGABA,max
(Table 2). Thus, we infer that there is not a signiﬁcant
amount of disulﬁde bond formation during oxidation in the
presence of potentiating concentrations of these anesthetics.
The small increases in holding current may arise because of
a small amount of direct activation at the anesthetic concen-
trations used.
Effect of Cu:phen oxidation in the presence of
activating anesthetic concentrations
A 1-min application of Cu:phen in the presence of directly
activating concentrations of propofol and pentobarbital had
two effects on the double Cys mutant a1T261Cb1T256C
(Fig. 5 and Table 2). It increased the subsequent holding
FIGURE 2 Effect of Cu:phen-induced oxidation in
the presence of GABA on single-channel currents
recorded froma1b1T256C-containing receptors. (A and
B) All-points histogram of currents recorded from an
HEK 293 cell in the cell-attached conﬁguration (left)
and the corresponding current recordings (right). The
pipette did not contain GABA. The pipette voltage was
clamped to 160 mV (hyperpolarization of the cell).
Data traces were numerically ﬁltered to 1 kHz for
display using QuB Software (59). The scale bars re-
present 2 pA and 50 ms. (A) Cell-attached patch re-
cording from a cell expressing a1b1T256C receptors.
No GABAA receptor channel activity was observed.
The current amplitude histogram was ﬁtted by a
Gaussian distribution centered around 0.05 6 0.1
pA. (B) Cell-attached patch recording from an
a1b1T256C-transfected cell that was treated with
Cu:phen in the presence of 5 mM GABA for 10–15
min. Before patch formation, GABA and Cu:phen were
thoroughly washed out of the dish. After oxidation in
the presence of GABA, a signiﬁcant amount of single-
channel activity was observed with no GABA in the
pipette. The current amplitudes were best ﬁtted using
the sum of two Gaussian distributions centered around
0.066 0.22 pA, relative area¼ 82%, and 1.196 0.34
pA, relative area ¼ 18%.
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current and decreased the subsequent GABA-induced cur-
rents. In the presence of 40 mM propofol, Cu:phen ap-
plication increased the holding current to 44 6 17% (n ¼ 5)
of the initial IGABA,max. In the presence of 1 mM pentobar-
bital, Cu:phen application increased the holding current to
28 6 7% (n ¼ 3) of the initial IGABA,max. We infer that the
increase in the holding current after Cu:phen application in
the presence of activating concentrations of these anesthetics
was caused by disulﬁde bond formation that signiﬁcantly
increased the channels’ spontaneous open probability. As a
percentage of the maximal GABA current, the holding cur-
rent increase was similar regardless of whether Cu:phen was
coapplied with GABA, propofol, or pentobarbital. The in-
crease was signiﬁcantly greater than the effect of application
of Cu:phen alone (Table 2). After washout of the anesthetic
and Cu:phen, in some experiments, the holding current
relaxed over a 10- to 20-min period to a smaller value,
although rarely back to the original baseline value. This
relaxation may be the result of endocytosis of receptors from
the cell surface and their replacement by unmodiﬁed receptors,
as was previously reported (39). This was rarely observed
when Cu:phen oxidation was performed in the presence of
GABA (31). The basis for this difference in recovery is
uncertain, but the variability in the rates of endocytosis of
cell surface proteins in batches of Xenopus oocytes could
account for this difference (39,40).
Similar results were observed with propofol and pentobar-
bital on the a1b1T256C mutant (data not shown). With these
two anesthetics there was no effect of Cu:phen on the
a1T261Cb1 mutant (data not shown). Thus, disulﬁde bond
formation in the presence of directly activating concentrations
of the anesthetics required only the Cys in the b-subunit, just
as with disulﬁde bond formation in the presence of GABA.At
the 69 level in the channel, it appears that the a-subunit is
incapable of participating in disulﬁde bond formation. We
believe that this is because there are only two a-subunits,
and they are in nonadjacent positions around the central
channel axis.
Fig. 5 C illustrates the typical effect of coapplication of an
activating concentration of isoﬂurane and Cu:phen on a1b1
T256C receptors. As can be seen in the current traces in Fig.
5 C, the holding current increased and remained elevated
after washout of isoﬂurane and Cu:phen. After the subse-
quent application of GABA, however, there was a further
increase in the holding current. This was seen consistently in
the isoﬂurane 1 Cu:phen experiments. After a 1-min ap-
plication of Cu:phen in the presence of 20 mM isoﬂurane, the
holding current increased to 32 6 22% (n ¼ 4) of IGABA,max
for a1b1T256C receptors (Fig. 5 C and Table 2).
We previously showed in control experiments that Cu:phen
application to uninjected oocytes or to oocytes expressing
wild-type a1b1 receptors in the absence or in the presence of
GABA did not produce any signiﬁcant change in the oocyte
holding currents (31). Thus, we infer that the observed in-
crease in holding current is caused by disulﬁde bond forma-
tion in the Cys mutant GABAA receptors. We previously
noted that this increased holding current could not be
blocked by either picrotoxin or penicillin (31). We believe
that the disulﬁde bond may prevent these open channel
blockers from gaining access to their binding sites, which for
picrotoxin is thought to be at the 29 level (41). We also
FIGURE 3 Anesthetic concentration-response relationships for potentia-
tion and direct activation. (A) Current traces from an oocyte expressing
a1T261Cb1T256C receptors. Periods of GABA and propofol application are
indicated by the black bars above the current traces. Propofol concentration
(mM) is indicated above bars. GABA concentration was 0.4 mM except
for the second trace, where it was 20 mM. Traces are separated by 5-min
washout periods. (B) Pentobarbital direct activation and potentiation of
GABA currents from an oocyte expressing a1T261Cb1T256C receptors.
Periods of GABA and pentobarbital application are indicated by the black
bars above the current traces. Pentobarbital concentration (mM) is indicated
above bars. The prominent rebound currents seen after pentobarbital and
GABA washout, particularly in the 300 and 1000 mM pentobarbital appli-
cations, represent relief of inhibition by pentobarbital. Traces are separated by
5-min washout periods. (C) Potentiating isoﬂurane concentration responses
on current traces from an oocyte expressinga1b1T256C receptors. Isoﬂurane
concentration (mM) above the bars. GABA concentration was 0.5 mM. (D)
Direct activation and inhibition by isoﬂurane. Current traces from an oocyte
expressing a1b1T256C receptors. Isoﬂurane concentration was 20 mM,
GABA concentration was 5 mM.
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previously showed that the reducing agent dithiothreitol
(DTT) did not reverse the effects of disulﬁde bond formation
at the 69 level, nor did EDTA (31). Presumably, once formed,
the 69 disulﬁde bond is inaccessible to DTT in intact channels.
We know that a disulﬁde bond is formed because dimers
were present on Western blots that in SDS could be reduced
with DTT to monomers (31).
DISCUSSION
These experiments sought to elucidate the structural conse-
quences of general anesthetic binding to GABAA receptors
in the region of the ion channel. We used disulﬁde-trapping
experiments to investigate the conformational changes in the
M2 channel-lining segment after anesthetic binding. Al-
though this provides only low-resolution structural informa-
tion, it does provide a basis for comparing conformational
changes induced by GABA with those induced by general
anesthetics. We used the state dependence of disulﬁde bond
formation between engineered Cys residues at the M2 seg-
ment 69 position as a reporter for anesthetic-induced con-
formational changes in this channel-lining region. We showed
previously that disulﬁde bonds formed at a measurable rate
between Cys residues in a1T261Cb1T256C receptors only
when Cu:phen-induced oxidation occurred in the presence of
GABA (31). This resulted in an increase in the holding
current after Cu:phen washout. We have now shown that the
increased macroscopic holding current resulted from a sig-
niﬁcant increase in the channel’s spontaneous open proba-
bility (Fig. 2). Strikingly, even with a disulﬁde bond at the 69
level between two adjacent channel-lining M2 segments, the
channels can still ﬂuctuate between the open and closed
states, as reﬂected by the ﬂickering activity during bursts
(Fig. 2 B). Furthermore, the channels can enter longer-lasting
desensitized states that likely account for the long noncon-
ducting intervals that we observed between bursts (Fig. 2 B).
This implies that even with the 69 disulﬁde bond there is
sufﬁcient mobility in the remaining three subunits and/or in
the more extracellular portions of the M2 segments of the
disulﬁde-linked pair to allow opening and closing of the
channel gate(s).
We infer that the increase in spontaneous openings occurs
because the disulﬁde bond distorts the channel structure
sufﬁciently to reduce the energy barrier for channels entering
the open state in the absence of agonist. We hypothesize that
channel opening may induce a conformational change at the
69 level that brings the engineered Cys on adjacent subunits
into close proximity. This allows disulﬁde bond formation to
occur. The disulﬁde bond presumably stabilizes this region
TABLE 1 Anesthetic concentrations used
Potentiating concentraion (mM) Activating conc. (mM)
Mutant Propofol Pentobarbital Isoﬂurane Propofol Pentobarbital Isoﬂurane
a1T261Cb1T256C 0.002 0.03 ND 0.04 1 ND
a1b1T256C 0.002 0.03 1 0.04 1 20*
ND, not done.
*Although the mean current induced by 20 mM isoﬂurane was only 3 6 0.6% (n ¼ 7) of the maximal GABA-induced current, the current was not corrected
for the signiﬁcant amount of inhibition that was also observed at this isoﬂurane concentration.
FIGURE 4 Effect of Cu:phen-induced oxidation in the presence of
potentiating concentrations of propofol and pentobarbital on currents from
oocytes expressing a1T261Cb1T256C receptors. Dotted line indicates the
initial holding current level. Note that the resting holding currents indicated
by the initial currents at the start of the traces after Cu:phen application are
similar to the initial holding currents before Cu:phen application. Periods of
reagent application are indicated by the black bars above the current traces.
(A) Oxidation in the presence of a potentiating concentration of propofol,
2 mM. (B) Oxidation in the presence of a potentiating concentration of pento-
barbital, 30 mM.
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of the channels in a conformation similar to the open state,
thus increasing the spontaneous open probability. The fact
that the single-channel conductance is reduced in the disulﬁde-
linked channels suggests that their structure is not identical
to the open channel. Furthermore, neither picrotoxin nor
penicillin blocks the disulﬁde-cross-linked channels (31),
perhaps because the disulﬁde bond narrows the lumen or
reduces the ﬂexibility in this region and does not allow
picrotoxin to reach its binding site at the 29 level (41,42). The
disulﬁde bond may distort the structure of the more cyto-
plasmic portion of M2 that lines the narrowest portion of the
open channel. In the homologous ACh receptor, the 19 to
29 region appears to be the narrowest region of the open
channel (43–45). This region is likely to have a major impact
on single-channel conductance, but other more cytoplasmic
regions may also affect conductance as well (46).
The state dependence of the disulﬁde bond formation could
result from two factors. As alluded to above, channel open-
ing may induce a conformational change in the position of
the engineered Cys to bring them into close proximity to
allow disulﬁde bond formation. In addition, channel activa-
tion may open a closed channel gate in the 99–149 region
(26,29), allowing access of oxidants to the 69 engineered Cys
residues. The fact that disulﬁde bond formation increases the
spontaneous open probability implies that the channel con-
formation in the 69 region is likely to be different from that in
the closed state. This implies that channel gating induces
conformational changes at the 69 level, although the more
cytoplasmic region of the channel may be more rigid (47,48).
In the current experiments, we observed a signiﬁcant
increase in holding current after oxidation only in the presence
of activating concentrations of anesthetic. The magnitudes of
the increases were similar to those seen after oxidation in the
presence of GABA (Table 2). After oxidation in the presence
of potentiating concentrations of propofol and isoﬂurane,
there were small but not statistically signiﬁcant increases in
holding current. It is possible that potentiating concentrations
that we used induced sufﬁcient channel opening, i.e., low-
level direct activation, to allow small amounts of disulﬁde
TABLE 2 Initial leak and change in leak after Cu:phen as a
percentage of maximal GABA current (IGABA,max) for
a1T261Cb1T256C receptors
Initial leak (%)*
Leak after
Cu:phen, potentiating
conc. (%)*
Leak after
Cu:phen, activating
conc. (%)*
Alone 10 6 6 (9) 9 6 8 (10) NA
GABA 11 6 4 (6) NA 29 6 10 (6) y
Propofol 10 6 9 (12) 12 6 10 (7) 44 6 17 (5) y
Pentobarbital 11 6 4 (6) 1 6 0 (3) 28 6 7 (3) y
Isoﬂurane 6 6 4 (10) 13 6 3 (3) 32 6 22 (4) y
Data given as mean 6 SE (number of experiments). NA, not applicable.
*Percentage of IGABA, max.
ySigniﬁcantly different (P , 0.01) from initial leak by one-way ANOVA
with Dunnett’s post hoc test.
FIGURE 5 Effect of Cu:phen-induced oxidation in the presence of
directly activating concentrations of the three anesthetics. Top dotted line
indicates the initial holding current level. Lower dotted line indicates level of
holding current after Cu:phen application. Note the increase in holding
currents indicated by the arrows (between the dotted lines and indicated as
holding current). Also note the decrease in the subsequent GABA-induced
currents after application of Cu:phen. Periods of reagent applications are
indicated by the black bars above the current traces. (A) Oxidation in the
presence of an activating concentration of propofol, 40 mM. Oocyte
expressing a1T261Cb1T256C receptors. (B) Oxidation in the presence of
an activating concentration of pentobarbital, 1 mM. Oocyte expressing
a1T261Cb1T256C receptors. (C) Oxidation in the presence of an activating
concentration of isoﬂurane, 20 mM. At this isoﬂurane concentration there is
also a signiﬁcant amount of inhibition by isoﬂurane. Oocyte expressing
a1b1T256C receptors.
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bond formation. Given that the ability to form disulﬁde bonds
at this channel level appears to require channel activation
either byGABAor by the anesthetics and that once formed the
disulﬁde bonds increase the spontaneous open probability, we
infer that the conformational change being detected is directly
related to channel opening. Thus, we infer that activating con-
centrations of the anesthetics tested induced a conformational
change in the M2 segment 69 level similar to that induced by
GABA.
Our data suggest that channel activation by the intravenous
anesthetics propofol and pentobarbital produced a conforma-
tional change that allowed disulﬁde bond formation between
Cys residues substituted for the b-subunit M2 segment 69
residues. Similar results were obtained for the volatile an-
esthetic isoﬂurane. With isoﬂurane, however, reopening the
channels after disulﬁde bond formation seemed to increase the
holding current (Fig. 5C). This difference between isoﬂurane
and the intravenous anesthetics may imply that isoﬂurane
induced a somewhat different conformational change than
GABA and the intravenous anesthetics. Alternatively, at the
isoﬂurane concentration that we used, the extent of channel
block was signiﬁcantly greater than that with propofol or
pentobarbital. It is possible that disulﬁde bond formation in
isoﬂurane-blocked channels may cause isoﬂurane to become
trapped in the channel at an inhibitory binding site. Subse-
quent activation byGABAmay release the trapped isoﬂurane,
allowing the increased spontaneous open probability to
become apparent. Evidence indicates that the isoﬂurane
inhibitory site may be near the M2 segment 29 position (49).
Thus, the disulﬁde bond at the 69 position could affect
isoﬂurane afﬁnity at a channel site that is only 6 A˚ away.
Consistent with the idea of an interaction between the 29 and
69 sites, covalent modiﬁcation of a1T261Cb1g2S receptors
markedly reduced the afﬁnity for picrotoxin, which binds at
the 29 level (41).
We previously showed using both an electrophysiological
assay and Western blots with epitope-tagged subunits that
the disulﬁde bonds at the 69 level formed between b-subunits;
disulﬁde bonds did not involve the a-subunits (31). The
results with the anesthetics using the electrophysiological
assay were consistent with the previously observed b-subunit
dependence. Oxidation in the presence of anesthetics of the
double Cys mutant a1T261Cb1T256C and the single b Cys
mutant, a1b1T256C, had similar effects. Oxidation in the
presence of anesthetics did not affect the single a Cys
mutant, a1T261Cb1. Because the major subunit stoichiom-
etry in ab receptors is two a- and three b-subunits (17–19),
and because disulﬁde bond formation increased the sponta-
neous open probability, we inferred that the bond likely
formed between Cys residues in adjacent b-subunits. We felt
that disulﬁde bond formation between Cys in nonadjacent
subunits would block the channel lumen at this level. Thus,
the formation of the 69 disulﬁde bond appeared to involve
subunit 5, the one not involved in forming a GABA binding
site, and the adjacent b subunit. Perhaps there is an
asymmetry in the channel, two pairs of b-a subunits form
GABA binding sites and effectively form functional units
relative to subunit 5, which is a b-subunit in the case of ab
receptors or the g-subunit in the case of abg receptors. We
suggested that the disulﬁde bond was able to form because
channel opening involved an asymmetric movement at the
b-b subunit interface either in time or in space (31). It is
interesting that with the anesthetics as channel activators we
observe a similar b-Cys subunit dependence for disulﬁde
bond formation. Thus, regardless of whether the channel is
opened by GABA binding in the GABA binding sites or by
anesthetic binding at activation sites that remain to be iden-
tiﬁed, the open-state channel conformations appear structur-
ally similar.
Our experimental evidence of the structural similarity of
the GABA and anesthetic open-state conformations is
consistent with functional studies that have shown similar
single-channel conductances regardless of whether GABAA
receptor channels are opened by GABA or by anesthetics,
leading to the hypothesis that the open-channel structures
would also be similar (12,13). Thus, although the binding
sites for these various agonists, GABA, propofol, pentobar-
bital, and isoﬂurane, may be at different locations in the
protein (6–8,50,51), the open-state conformation that they
induce is similar. In the homologous nicotinic acetylcholine
receptor, using linear free energy relationships, a conforma-
tional wave has been measured from the acetylcholine bind-
ing site in the extracellular domain to the cytoplasmic end of
the channel (52,53). It would be interesting to determine
whether the conformational wave induced by GABA binding
is similar to that induced by the anesthetics. This may be
particularly useful in determining whether activation by
anesthetics occurs through binding in the membrane-span-
ning domain or in the extracellular domain.
Propofol, at potentiating concentrations, induced confor-
mational change in the membrane-spanning domain that in-
creased the accessibility ofa1 subunit,M3 segment, substituted
Cys residues to the sulfhydryl reagent pCMBS (11). It did not,
however, facilitate a signiﬁcant amount of disulﬁde bond
formation at theM2segment 69 level. Thus, propofol binding at
its potentiating site(s) stabilizes a membrane-spanning domain
conformationor ensemble of conformations that is/are different
from the closed and open states. This is consistent with the
conclusions of studies of propofol’s effects on channel kinetics.
These indicate that propofol stabilizes a doubly liganded,
preopen state (9). Current evidence suggests that the propofol
potentiation binding site is located near the extracellular end of
the M2 and M3 membrane-spanning segments (2,38). Similar
locations have been suggested for isoﬂurane and pentobarbital
(54,55).
Of note, Lynch and co-workers reported that in HEK293
cells they did not observe Cu:phen-induced increases in
holding current (56). It is possible that the difference may
arise because some HEK cells lines have been shown to
express signiﬁcant levels of endogenous wild-type b-subunit
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(57,58). Given the b-subunit dependence that we observed
at the 69 level, the coexpression of endogenous wild-type
b-subunits would have a major impact on the results. Further
work will be necessary to clarify these issues.
In summary, the current experiments provide structural
evidence to support the hypothesis that at concentrations that
activate GABAA receptors, general anesthetics induce a sim-
ilar ion channel conformation as that induced by GABA
activation. These experiments also indicate that the confor-
mational change that is required to facilitate 69 disulﬁde bond
formation is associated with channel opening. Anesthetic
binding at the potentiating binding site(s) does not induce
this M2 segment structural change to a signiﬁcant extent.
This implies that the structural changes in the M3 segment
region detected in the presence of potentiating concentra-
tions of propofol (11) represent states between the closed and
open states. Thus, a picture is starting to emerge of the
sequence of conformational changes that occur during
channel gating by GABA and by anesthetics.
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